Literature DB >> 20650925

Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications.

Felix Stickel1, Claus Hellerbrand.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20650925     DOI： 10.1136/gut.2009.199661

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  61 in total

1.  Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.

Authors:  Bernd Schnabl; Barbara Czech; Daniela Valletta; Thomas S Weiss; Georgi Kirovski; Claus Hellerbrand
Journal:  Int J Clin Exp Pathol       Date:  2011-09-22

2.  Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Pavel Vladimirovich Korita; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

3.  FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy.

Authors:  Shenglong Zhu; Yunzhou Wu; Xianlong Ye; Lei Ma; Jianying Qi; Dan Yu; Yuquan Wei; Guangxiao Lin; Guiping Ren; Deshan Li
Journal:  Mol Cell Biochem       Date:  2016-07-19       Impact factor: 3.396

Review 4.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

5.  Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.

Authors:  Zhen-Ya Lu; Zhou Shao; Ya-Li Li; Muhuyati Wulasihan; Xin-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

6.  Metabolic syndrome-related hepatocellular carcinoma treated by volumetric modulated arc therapy.

Authors:  J Klein; L A Dawson; T H Tran; O Adeyi; T Purdie; M Sherman; A Brade
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

7.  Characterization of polybrominated diphenyl ether toxicity in Wistar Han rats and use of liver microarray data for predicting disease susceptibilities.

Authors:  June K Dunnick; A Brix; H Cunny; M Vallant; K R Shockley
Journal:  Toxicol Pathol       Date:  2012       Impact factor: 1.902

Review 8.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

9.  Fructose stimulated de novo lipogenesis is promoted by inflammation.

Authors:  Jelena Todoric; Giuseppe Di Caro; Saskia Reibe; Darren C Henstridge; Courtney R Green; Alison Vrbanac; Fatih Ceteci; Claire Conche; Reginald McNulty; Shabnam Shalapour; Koji Taniguchi; Peter J Meikle; Jeramie D Watrous; Rafael Moranchel; Mahan Najhawan; Mohit Jain; Xiao Liu; Tatiana Kisseleva; Maria T Diaz-Meco; Jorge Moscat; Rob Knight; Florian R Greten; Lester F Lau; Christian M Metallo; Mark A Febbraio; Michael Karin
Journal:  Nat Metab       Date:  2020-08-24

10.  Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.

Authors:  Ryan B Perumpail; Robert J Wong; Aijaz Ahmed; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2015-08-07       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.